Skip to content
EMREmerson Electric

What Is EMR Fair Value?

Emerson Electric (EMR) fair value estimate using multiple valuation models, updated daily.

As of July 16, 2026, Emerson Electric (EMR) has a composite fair value estimate of $77.06 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $136.25, suggesting the stock is overvalued by 43.4%.

Data as of July 16, 2026 (today)

Composite Fair Value

Overvalued4 of 4 models

$77.06

vs. current price of $136.25(-43.4%)

Undervalued$77.06Overvalued
$136.25

How Is EMR Fair Value Calculated?

Four independent models estimate what EMR is worth. Each uses different inputs and assumptions. The composite blends them by weight.

EMR Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$90.65

-33.5%

Overvalued

Inputs used

FCF: 3.3BGrowth: 9.4%Discount: 10%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$34.98

-74.3%

Overvalued

Inputs used

Dividend: $2.22/yrReq. Return: 11%Growth: 4.7%

EMR Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$72.87

-46.5%

Overvalued

Inputs used

EPS: $6.51Book Value: $36.25

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$65.10

-52.2%

Overvalued

Inputs used

EPS: $6.51Growth: 9.4%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$90.65Overvalued

Current price $136.25 is 33.5% above this estimate

CheapFair ValueExpensive
9.4%
0.0%30.0%
10.2%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$3.58B$3.25B
Year 2$3.92B$3.23B
Year 3$4.28B$3.20B
Year 4$4.69B$3.18B
Year 5$5.13B$3.16B
Year 6$5.61B$3.13B
Year 7$6.14B$3.11B
Year 8$6.71B$3.09B
Year 9$7.34B$3.07B
Year 10$8.03B$3.04B
Terminal Value$107.03B$40.55B

What Are EMR's Key Financial Metrics?

Earnings & Growth

Current Price

$136.25

EPS (TTM)

$4.32

Forward P/E

19.0

Profit Margin

13.4%

Cash & Balance Sheet

Free Cash Flow

3.3B

EBITDA

5.9B

Book Value

$36.25

Total Debt

14.1B

What Do Analysts Say About EMR?

Low

$104.00

Average

$163.76

High

$203.00

Upside

+20.2%

Current $136.25Avg Target $163.76Buy27 analysts

EMR Fair Value FAQ

What is the fair value of EMR?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), EMR's estimated fair value is $77.06. The stock is currently trading at $136.25, which makes it overvalued by our analysis.

How is EMR's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is EMR overvalued or undervalued?

Based on our analysis, EMR is overvalued. The current price of $136.25 is 43.4% above our estimated fair value of $77.06.

What do Wall Street analysts say about EMR?

27 analysts cover Emerson Electric with a consensus rating of "Buy." The average price target is $163.76, ranging from $104.00 to $203.00. This implies 20.2% upside from the current price.